Status:
COMPLETED
Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention
Lead Sponsor:
University of Santiago de Compostela
Conditions:
Oral Mucositis
Osteoradionecrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction: There are several manifestations in the oral mucosa resulting from antineoplastic treatments by chemo (QT) or radiotherapy (RT). In this study we will collect the variables referring to ...
Eligibility Criteria
Inclusion
- Patients with head and neck or breast cancer who will undergo chemotherapy or radiotherapy.
Exclusion
- Participants who do not sign the informed consent.
- Patients who have been or will be treated by chemo and radiotherapy together.
- Patients in treatment of a cancer recurrence.
- Patients reporting diabetes or sjogren's syndrome.
Key Trial Info
Start Date :
February 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04717765
Start Date
February 10 2021
End Date
August 31 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico Universitário
Santiago de Compostela, LA Coruña, Spain, 15702